Abstract
Glycaemic control still proves to be an elusive goal for many with type 2 diabetes. While there has been major progress made, we remain a considerable distance from achieving optimal care for people with diabetes, writes Mark Greener
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
